Athena Athena

X

Find the latest Drugs in Development and Pipeline Prospector News of Odimma Therapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Odimma Therapeutics
France Flag
Country
Country
France
Address
Address
Immeuble le Pythagore 1 rue Jean Sapidus Parc d'Innovation 67400 ILLKIRCH
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

The financing will secure the preparation on Odimma's First-in-Man clinical trial with ODI-2001, an innovative first-in-class personalized immunotherapy against cancer.


Lead Product(s): ODI-2001

Therapeutic Area: Oncology Product Name: ODI-2001

Highest Development Status: PreclinicalProduct Type: Large molecule

Partner/Sponsor/Collaborator: Capital Grand Est

Deal Size: $2.2 million Upfront Cash: Undisclosed

Deal Type: Financing May 02, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Odimma will gain access to Touchlight’s proprietary doggybone DNA (dbDNA™) vector technology, providing them with a clinical supply of personalised dbDNA™, to support and underpin the development of their candidate immunotherapy cancer treatment.


Lead Product(s): Undisclosed

Therapeutic Area: Oncology Product Name: Undisclosed

Highest Development Status: DiscoveryProduct Type: Cell and Gene therapy

Recipient: Touchlight

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement December 07, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

ABL will manufacture the viral component of Odimma's innovative and proprietary immunization platform ODI-2001. The viral component present in ODI-2001 plays the role of both a strong immune adjuvant and of a carrier for the DNA vector expressing personalized neoantigens.


Lead Product(s): ODI-2001

Therapeutic Area: Oncology Product Name: ODI-2001

Highest Development Status: PreclinicalProduct Type: Vaccine

Partner/Sponsor/Collaborator: ABL Europe

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement May 17, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY